Bolt Biotherapeutics Future Growth
Future criteria checks 2/6
Bolt Biotherapeutics's earnings are forecast to decline at 2.1% per annum while its annual revenue is expected to grow at 31.9% per year. EPS is expected to grow by 17.5% per annum. Return on equity is forecast to be -64.7% in 3 years.
Key information
-2.1%
Earnings growth rate
17.5%
EPS growth rate
| Biotechs earnings growth | 20.7% |
| Revenue growth rate | 31.9% |
| Future return on equity | -64.7% |
| Analyst coverage | Low |
| Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully
Mar 15
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
May 13Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
Dec 01Bolt Biotherapeutics: A Promised Follow Up
Aug 26Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M
Aug 10We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Jul 27We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Apr 12We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth
Dec 03Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies
Aug 18We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely
Aug 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 56 | -51 | N/A | -75 | 4 |
| 12/31/2025 | 24 | -68 | N/A | -77 | 5 |
| 12/31/2024 | 10 | -81 | N/A | -67 | 3 |
| 12/31/2023 | 8 | -69 | -70 | -70 | N/A |
| 9/30/2023 | 7 | -71 | -74 | -73 | N/A |
| 6/30/2023 | 7 | -77 | -71 | -70 | N/A |
| 3/31/2023 | 7 | -81 | -77 | -76 | N/A |
| 12/31/2022 | 6 | -88 | -78 | -77 | N/A |
| 9/30/2022 | 5 | -95 | -79 | -76 | N/A |
| 6/30/2022 | 3 | -97 | -84 | -82 | N/A |
| 3/31/2022 | 2 | -98 | -68 | -65 | N/A |
| 12/31/2021 | 1 | -99 | -59 | -57 | N/A |
| 9/30/2021 | 1 | -102 | -55 | -52 | N/A |
| 6/30/2021 | N/A | -89 | -49 | -46 | N/A |
| 3/31/2021 | 0 | -77 | -57 | -54 | N/A |
| 12/31/2020 | 0 | -61 | -51 | -47 | N/A |
| 9/30/2020 | 0 | -39 | -43 | -41 | N/A |
| 6/30/2020 | 0 | -36 | -38 | -36 | N/A |
| 3/31/2020 | 0 | -32 | -31 | -30 | N/A |
| 12/31/2019 | 0 | -30 | -27 | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BOLT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BOLT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BOLT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BOLT's revenue (31.9% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: BOLT's revenue (31.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BOLT is forecast to be unprofitable in 3 years.